Astellas’ gastric cancer therapy gets the go-ahead from UK regulator
The UK health regulator said it approved Astellas Pharma’s therapy to treat a type of gastric cancer. The monoclonal antibody, which will be marketed under the brand name Vyloy, can recognise certain cancer cells and attach to and destroy them.
POPULAR POSTS
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
Mission: Impossible 8 title revealed
November 13, 2024
LIVE STREAM